» Articles » PMID: 21977256

Myocardial Infarction in Major Noncardiac Surgery: Epidemiology, Pathophysiology and Prevention

Overview
Journal Heart Int
Date 2011 Oct 7
PMID 21977256
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The number of subjects undergoing major noncardiac surgery who are at risk for perioperative myocardial infarction (MI) is growing worldwide.It has been estimated that 500,000 to 900,000 patients suffer major perioperative cardiovascular complications every year, with consequent heavy, long-term prognostic implications and costs.It is well known that perioperative MIs don't share the same pathophysiology as nonsurgical MIs but the relative role of the different, potential triggers has not been completely clarified.Many aspects of the perioperative management, including risk-stratification and prophylactic or postoperative interventions have also not been completely defined.Throughout recent years many resources have been invested to clarify these aspects and experts have developed indices and algorithm-based strategies to better assess the cardiac risk and to guide the perioperative management.The scope of the present review is to discuss the main aspects of perioperative MI in noncardiac surgery, with particular regard to epidemiology, pathophysiology, preoperative risk stratification, prophylaxis and therapy.

Citing Articles

Reproducible transient asystolic arrest during intramedullary reaming of the femoral canal: A case report.

Wooster B, Nickel B, Neumann J, Lindsay D, Wellman S J Clin Orthop Trauma. 2017; 8(Suppl 1):S58-S61.

PMID: 28878543 PMC: 5574862. DOI: 10.1016/j.jcot.2017.07.010.


Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis.

Suzumura E, Ribeiro R, Kawano-Dourado L, de Barros E Silva P, Oliveira C, Figueiro M Syst Rev. 2017; 6(1):116.

PMID: 28629445 PMC: 5477118. DOI: 10.1186/s13643-017-0500-0.


Perioperative cardioprotection.

Leung M, Irwin M F1000Prime Rep. 2013; 5:7.

PMID: 23513179 PMC: 3590787. DOI: 10.12703/P5-7.

References
1.
Schouten O, Poldermans D, Visser L, Kertai M, Klein J, van Urk H . Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J. 2005; 148(6):1047-52. DOI: 10.1016/j.ahj.2004.05.046. View

2.
Durazzo A, Machado F, Ikeoka D, De Bernoche C, Monachini M, Puech-Leao P . Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004; 39(5):967-75. DOI: 10.1016/j.jvs.2004.01.004. View

3.
Almanaseer Y, Mukherjee D, Kline-Rogers E, Kesterson S, Sonnad S, Rogers B . Implementation of the ACC/AHA guidelines for preoperative cardiac risk assessment in a general medicine preoperative clinic: improving efficiency and preserving outcomes. Cardiology. 2004; 103(1):24-9. DOI: 10.1159/000081848. View

4.
Wijeysundera D, Beattie W . Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg. 2003; 97(3):634-641. DOI: 10.1213/01.ANE.0000081732.51871.D2. View

5.
Fuster V, Badimon L, Badimon J, Chesebro J . The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992; 326(5):310-8. DOI: 10.1056/NEJM199201303260506. View